Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
165 hedge funds and large institutions have $1.18B invested in Amedisys in 2015 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 64 increasing their positions, 53 reducing their positions, and 24 closing their positions.
484% more call options, than puts
Call options by funds: $7.48M | Put options by funds: $1.28M
21% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 53
3% more capital invested
Capital invested by funds: $1.15B → $1.18B (+$37.6M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less funds holding
Funds holding: 173 → 165 (-8)
21% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 24
Top Buyers
Top Sellers
AMED Hedge Fund Activity: Q4 2015 in Review
165 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q4 2015, worth a combined $1.18B — up 3.3% from $1.15B a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of AMED and 19 opened new positions — a net loss of 5 holders — while 53 trimmed existing stakes and 64 added.
The largest buyer was Fidelity Investments, adding an estimated $18.5M. The largest seller was North Tide Capital, cutting an estimated $80M.
- 165 institutional investors held Amedisys (AMED) as of Q4 2015, down from 173 in Q3 2015.
- Funds reported $1.18B of Amedisys stock for Q4 2015, up 3.3% quarter-over-quarter.
- 19 funds opened new Amedisys positions in Q4 2015 and 24 closed out, a net change of -5 holders.
- The largest Amedisys buyer in Q4 2015 was Fidelity Investments, an estimated $18.5M added.
- The largest Amedisys seller in Q4 2015 was North Tide Capital, an estimated $80M sold.
Based on aggregated 13F filings for Q4 2015.